Edward C. Moffat is suing 3M, DuPont, and other major chemical companies for personal injury due to PFAS exposure from firefighting foams during his Navy service. The lawsuit highlights severe health risks, including kidney cancer, linked to PFAS. Key claims include defective design, failure to warn, negligence, and fraudulent concealment. This case could set significant legal precedents and result in substantial settlements, reflecting broader trends in PFAS and AFFF litigation, particularly as it pertains to cases affecting military servicemembers.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting veterans significantly. The VA offers disability ratings for UC, ranging from 10% to 100%, based on severity and daily impact. Key causes include genetic factors, immune system dysfunction, environmental toxins like PFAS chemicals, and lifestyle factors. Symptoms include severe diarrhea, abdominal pain, and weight loss. Veterans seeking benefits must provide comprehensive medical evidence, submit a claim, and undergo a C&P exam. Understanding these ratings and the application process can help veterans manage their condition and improve their quality of life.
Uncover the shocking reality of water contamination at over 455 military bases, putting servicemembers' and families' health at risk from PFAS, benzene, and other harmful substances. This article delves into the Pentagon's delayed response, a landmark $1.185 billion settlement, and offers a practical guide for affected individuals seeking legal action and compensation for their health issues.
Discover the critical link between military service and heightened cancer risks among veterans. Learn how the PACT Act of 2022 has revolutionized VA health care, providing vital support and streamlined benefits for toxic exposure-related conditions. Explore the urgent need for more research on PFAS chemicals and the holistic approach to veteran healthcare.
Navigate the VA disability rating system for veterans with cancer in remission. Learn how the VA evaluates active versus remission states, accounts for residual treatment effects, and manages risk of recurrence. Our legal experts stress the importance of thorough documentation to optimize your benefits and secure the compensation you deserve for service-connected cancer in remission.